 | • レポートコード：QYR2104Z0873 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、出血性疾患のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（血漿由来凝固因子濃縮物、組換え凝固因子濃縮物、デスモプレシン、抗線溶薬、フィブリンシーラント、その他）、用途別市場規模（血友病A、血友病B、フォンウィルブランド病、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・出血性疾患の市場動向 ・企業の競争状況、市場シェア ・出血性疾患の種類別市場規模（血漿由来凝固因子濃縮物、組換え凝固因子濃縮物、デスモプレシン、抗線溶薬、フィブリンシーラント、その他） ・出血性疾患の用途別市場規模（血友病A、血友病B、フォンウィルブランド病、その他） ・出血性疾患の北米市場規模2016-2027（アメリカ、カナダ） ・出血性疾患のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・出血性疾患のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・出血性疾患の中南米市場規模2016-2027（メキシコ、ブラジル） ・出血性疾患の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Novo Nordisk、Bayer、Baxter International、Alnylam Pharmaceuticals、Pfizer、Xenetic Biosciences、Bristol-Myers Squibb Company、Sanofi、Janssen Global Services、Bioverativ、Amgen） ・結論 |
The bleeding disorder is a condition in which there is a problem associated with the normal blood clotting process in the body, which gets affected. Hence, therapies to stop bleeding are on high demand.
Market Analysis and Insights: Global Bleeding Disorders Market
The global Bleeding Disorders market size is projected to reach US$ 16780 million by 2026, from US$ 10810 million in 2019, at a CAGR of 6.4% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Bleeding Disorders market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Bleeding Disorders market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Bleeding Disorders market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Bleeding Disorders market.
Global Bleeding Disorders Scope and Market Size
Bleeding Disorders market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Bleeding Disorders market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Plasma-derived Coagulation Factor Concentrates
Recombinant Coagulation Factor Concentrates
Desmopressin
Antifibrinolytics
Fibrin Sealants
Others
Segment by Application
Hemophilia A
Hemophilia B
Von Willebrand Disease
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Novo Nordisk
Bayer
Baxter International
Alnylam Pharmaceuticals
Pfizer
Xenetic Biosciences
Bristol-Myers Squibb Company
Sanofi
Janssen Global Services
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Bleeding Disorders Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Plasma-derived Coagulation Factor Concentrates
1.2.3 Recombinant Coagulation Factor Concentrates
1.2.4 Desmopressin
1.2.5 Antifibrinolytics
1.2.6 Fibrin Sealants
1.2.7 Others
1.3 Market by Application
1.3.1 Global Bleeding Disorders Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hemophilia A
1.3.3 Hemophilia B
1.3.4 Von Willebrand Disease
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Bleeding Disorders Market Perspective (2016-2027)
2.2 Bleeding Disorders Growth Trends by Regions
2.2.1 Bleeding Disorders Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Bleeding Disorders Historic Market Share by Regions (2016-2021)
2.2.3 Bleeding Disorders Forecasted Market Size by Regions (2022-2027)
2.3 Bleeding Disorders Industry Dynamic
2.3.1 Bleeding Disorders Market Trends
2.3.2 Bleeding Disorders Market Drivers
2.3.3 Bleeding Disorders Market Challenges
2.3.4 Bleeding Disorders Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Bleeding Disorders Players by Revenue
3.1.1 Global Top Bleeding Disorders Players by Revenue (2016-2021)
3.1.2 Global Bleeding Disorders Revenue Market Share by Players (2016-2021)
3.2 Global Bleeding Disorders Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Bleeding Disorders Revenue
3.4 Global Bleeding Disorders Market Concentration Ratio
3.4.1 Global Bleeding Disorders Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Bleeding Disorders Revenue in 2020
3.5 Bleeding Disorders Key Players Head office and Area Served
3.6 Key Players Bleeding Disorders Product Solution and Service
3.7 Date of Enter into Bleeding Disorders Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Bleeding Disorders Breakdown Data by Type
4.1 Global Bleeding Disorders Historic Market Size by Type (2016-2021)
4.2 Global Bleeding Disorders Forecasted Market Size by Type (2022-2027)
5 Bleeding Disorders Breakdown Data by Application
5.1 Global Bleeding Disorders Historic Market Size by Application (2016-2021)
5.2 Global Bleeding Disorders Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Bleeding Disorders Market Size (2016-2027)
6.2 North America Bleeding Disorders Market Size by Type
6.2.1 North America Bleeding Disorders Market Size by Type (2016-2021)
6.2.2 North America Bleeding Disorders Market Size by Type (2022-2027)
6.2.3 North America Bleeding Disorders Market Size by Type (2016-2027)
6.3 North America Bleeding Disorders Market Size by Application
6.3.1 North America Bleeding Disorders Market Size by Application (2016-2021)
6.3.2 North America Bleeding Disorders Market Size by Application (2022-2027)
6.3.3 North America Bleeding Disorders Market Size by Application (2016-2027)
6.4 North America Bleeding Disorders Market Size by Country
6.4.1 North America Bleeding Disorders Market Size by Country (2016-2021)
6.4.2 North America Bleeding Disorders Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Bleeding Disorders Market Size (2016-2027)
7.2 Europe Bleeding Disorders Market Size by Type
7.2.1 Europe Bleeding Disorders Market Size by Type (2016-2021)
7.2.2 Europe Bleeding Disorders Market Size by Type (2022-2027)
7.2.3 Europe Bleeding Disorders Market Size by Type (2016-2027)
7.3 Europe Bleeding Disorders Market Size by Application
7.3.1 Europe Bleeding Disorders Market Size by Application (2016-2021)
7.3.2 Europe Bleeding Disorders Market Size by Application (2022-2027)
7.3.3 Europe Bleeding Disorders Market Size by Application (2016-2027)
7.4 Europe Bleeding Disorders Market Size by Country
7.4.1 Europe Bleeding Disorders Market Size by Country (2016-2021)
7.4.2 Europe Bleeding Disorders Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Bleeding Disorders Market Size (2016-2027)
8.2 Asia-Pacific Bleeding Disorders Market Size by Type
8.2.1 Asia-Pacific Bleeding Disorders Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Bleeding Disorders Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Bleeding Disorders Market Size by Type (2016-2027)
8.3 Asia-Pacific Bleeding Disorders Market Size by Application
8.3.1 Asia-Pacific Bleeding Disorders Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Bleeding Disorders Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Bleeding Disorders Market Size by Application (2016-2027)
8.4 Asia-Pacific Bleeding Disorders Market Size by Region
8.4.1 Asia-Pacific Bleeding Disorders Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Bleeding Disorders Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Bleeding Disorders Market Size (2016-2027)
9.2 Latin America Bleeding Disorders Market Size by Type
9.2.1 Latin America Bleeding Disorders Market Size by Type (2016-2021)
9.2.2 Latin America Bleeding Disorders Market Size by Type (2022-2027)
9.2.3 Latin America Bleeding Disorders Market Size by Type (2016-2027)
9.3 Latin America Bleeding Disorders Market Size by Application
9.3.1 Latin America Bleeding Disorders Market Size by Application (2016-2021)
9.3.2 Latin America Bleeding Disorders Market Size by Application (2022-2027)
9.3.3 Latin America Bleeding Disorders Market Size by Application (2016-2027)
9.4 Latin America Bleeding Disorders Market Size by Country
9.4.1 Latin America Bleeding Disorders Market Size by Country (2016-2021)
9.4.2 Latin America Bleeding Disorders Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Bleeding Disorders Market Size (2016-2027)
10.2 Middle East & Africa Bleeding Disorders Market Size by Type
10.2.1 Middle East & Africa Bleeding Disorders Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Bleeding Disorders Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Bleeding Disorders Market Size by Type (2016-2027)
10.3 Middle East & Africa Bleeding Disorders Market Size by Application
10.3.1 Middle East & Africa Bleeding Disorders Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Bleeding Disorders Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Bleeding Disorders Market Size by Application (2016-2027)
10.4 Middle East & Africa Bleeding Disorders Market Size by Country
10.4.1 Middle East & Africa Bleeding Disorders Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Bleeding Disorders Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Novo Nordisk
11.1.1 Novo Nordisk Company Details
11.1.2 Novo Nordisk Business Overview
11.1.3 Novo Nordisk Bleeding Disorders Introduction
11.1.4 Novo Nordisk Revenue in Bleeding Disorders Business (2016-2021)
11.1.5 Novo Nordisk Recent Development
11.2 Bayer
11.2.1 Bayer Company Details
11.2.2 Bayer Business Overview
11.2.3 Bayer Bleeding Disorders Introduction
11.2.4 Bayer Revenue in Bleeding Disorders Business (2016-2021)
11.2.5 Bayer Recent Development
11.3 Baxter International
11.3.1 Baxter International Company Details
11.3.2 Baxter International Business Overview
11.3.3 Baxter International Bleeding Disorders Introduction
11.3.4 Baxter International Revenue in Bleeding Disorders Business (2016-2021)
11.3.5 Baxter International Recent Development
11.4 Alnylam Pharmaceuticals
11.4.1 Alnylam Pharmaceuticals Company Details
11.4.2 Alnylam Pharmaceuticals Business Overview
11.4.3 Alnylam Pharmaceuticals Bleeding Disorders Introduction
11.4.4 Alnylam Pharmaceuticals Revenue in Bleeding Disorders Business (2016-2021)
11.4.5 Alnylam Pharmaceuticals Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Bleeding Disorders Introduction
11.5.4 Pfizer Revenue in Bleeding Disorders Business (2016-2021)
11.5.5 Pfizer Recent Development
11.6 Xenetic Biosciences
11.6.1 Xenetic Biosciences Company Details
11.6.2 Xenetic Biosciences Business Overview
11.6.3 Xenetic Biosciences Bleeding Disorders Introduction
11.6.4 Xenetic Biosciences Revenue in Bleeding Disorders Business (2016-2021)
11.6.5 Xenetic Biosciences Recent Development
11.7 Bristol-Myers Squibb Company
11.7.1 Bristol-Myers Squibb Company Company Details
11.7.2 Bristol-Myers Squibb Company Business Overview
11.7.3 Bristol-Myers Squibb Company Bleeding Disorders Introduction
11.7.4 Bristol-Myers Squibb Company Revenue in Bleeding Disorders Business (2016-2021)
11.7.5 Bristol-Myers Squibb Company Recent Development
11.8 Sanofi
11.8.1 Sanofi Company Details
11.8.2 Sanofi Business Overview
11.8.3 Sanofi Bleeding Disorders Introduction
11.8.4 Sanofi Revenue in Bleeding Disorders Business (2016-2021)
11.8.5 Sanofi Recent Development
11.9 Janssen Global Services
11.9.1 Janssen Global Services Company Details
11.9.2 Janssen Global Services Business Overview
11.9.3 Janssen Global Services Bleeding Disorders Introduction
11.9.4 Janssen Global Services Revenue in Bleeding Disorders Business (2016-2021)
11.9.5 Janssen Global Services Recent Development
11.10 Bioverativ
11.10.1 Bioverativ Company Details
11.10.2 Bioverativ Business Overview
11.10.3 Bioverativ Bleeding Disorders Introduction
11.10.4 Bioverativ Revenue in Bleeding Disorders Business (2016-2021)
11.10.5 Bioverativ Recent Development
11.11 Amgen
11.11.1 Amgen Company Details
11.11.2 Amgen Business Overview
11.11.3 Amgen Bleeding Disorders Introduction
11.11.4 Amgen Revenue in Bleeding Disorders Business (2016-2021)
11.11.5 Amgen Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Bleeding Disorders Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Plasma-derived Coagulation Factor Concentrates
Table 3. Key Players of Recombinant Coagulation Factor Concentrates
Table 4. Key Players of Desmopressin
Table 5. Key Players of Antifibrinolytics
Table 6. Key Players of Fibrin Sealants
Table 7. Key Players of Others
Table 8. Global Bleeding Disorders Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Bleeding Disorders Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Bleeding Disorders Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Bleeding Disorders Market Share by Regions (2016-2021)
Table 12. Global Bleeding Disorders Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Bleeding Disorders Market Share by Regions (2022-2027)
Table 14. Bleeding Disorders Market Trends
Table 15. Bleeding Disorders Market Drivers
Table 16. Bleeding Disorders Market Challenges
Table 17. Bleeding Disorders Market Restraints
Table 18. Global Bleeding Disorders Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Bleeding Disorders Market Share by Players (2016-2021)
Table 20. Global Top Bleeding Disorders Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bleeding Disorders as of 2020)
Table 21. Ranking of Global Top Bleeding Disorders Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Bleeding Disorders Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Bleeding Disorders Product Solution and Service
Table 25. Date of Enter into Bleeding Disorders Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Bleeding Disorders Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Bleeding Disorders Revenue Market Share by Type (2016-2021)
Table 29. Global Bleeding Disorders Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Bleeding Disorders Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Bleeding Disorders Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Bleeding Disorders Revenue Market Share by Application (2016-2021)
Table 33. Global Bleeding Disorders Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Bleeding Disorders Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Bleeding Disorders Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Bleeding Disorders Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Bleeding Disorders Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Bleeding Disorders Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Bleeding Disorders Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Bleeding Disorders Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Bleeding Disorders Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Bleeding Disorders Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Bleeding Disorders Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Bleeding Disorders Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Bleeding Disorders Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Bleeding Disorders Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Bleeding Disorders Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Bleeding Disorders Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Bleeding Disorders Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Bleeding Disorders Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Bleeding Disorders Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Bleeding Disorders Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Bleeding Disorders Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Bleeding Disorders Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Bleeding Disorders Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Bleeding Disorders Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Bleeding Disorders Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Bleeding Disorders Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Bleeding Disorders Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Bleeding Disorders Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Bleeding Disorders Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Bleeding Disorders Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Bleeding Disorders Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Bleeding Disorders Market Size by Country (2022-2027) & (US$ Million)
Table 65. Novo Nordisk Company Details
Table 66. Novo Nordisk Business Overview
Table 67. Novo Nordisk Bleeding Disorders Product
Table 68. Novo Nordisk Revenue in Bleeding Disorders Business (2016-2021) & (US$ Million)
Table 69. Novo Nordisk Recent Development
Table 70. Bayer Company Details
Table 71. Bayer Business Overview
Table 72. Bayer Bleeding Disorders Product
Table 73. Bayer Revenue in Bleeding Disorders Business (2016-2021) & (US$ Million)
Table 74. Bayer Recent Development
Table 75. Baxter International Company Details
Table 76. Baxter International Business Overview
Table 77. Baxter International Bleeding Disorders Product
Table 78. Baxter International Revenue in Bleeding Disorders Business (2016-2021) & (US$ Million)
Table 79. Baxter International Recent Development
Table 80. Alnylam Pharmaceuticals Company Details
Table 81. Alnylam Pharmaceuticals Business Overview
Table 82. Alnylam Pharmaceuticals Bleeding Disorders Product
Table 83. Alnylam Pharmaceuticals Revenue in Bleeding Disorders Business (2016-2021) & (US$ Million)
Table 84. Alnylam Pharmaceuticals Recent Development
Table 85. Pfizer Company Details
Table 86. Pfizer Business Overview
Table 87. Pfizer Bleeding Disorders Product
Table 88. Pfizer Revenue in Bleeding Disorders Business (2016-2021) & (US$ Million)
Table 89. Pfizer Recent Development
Table 90. Xenetic Biosciences Company Details
Table 91. Xenetic Biosciences Business Overview
Table 92. Xenetic Biosciences Bleeding Disorders Product
Table 93. Xenetic Biosciences Revenue in Bleeding Disorders Business (2016-2021) & (US$ Million)
Table 94. Xenetic Biosciences Recent Development
Table 95. Bristol-Myers Squibb Company Company Details
Table 96. Bristol-Myers Squibb Company Business Overview
Table 97. Bristol-Myers Squibb Company Bleeding Disorders Product
Table 98. Bristol-Myers Squibb Company Revenue in Bleeding Disorders Business (2016-2021) & (US$ Million)
Table 99. Bristol-Myers Squibb Company Recent Development
Table 100. Sanofi Company Details
Table 101. Sanofi Business Overview
Table 102. Sanofi Revenue in Bleeding Disorders Business (2016-2021) & (US$ Million)
Table 103. Sanofi Recent Development
Table 104. Janssen Global Services Company Details
Table 105. Janssen Global Services Business Overview
Table 106. Janssen Global Services Bleeding Disorders Product
Table 107. Janssen Global Services Revenue in Bleeding Disorders Business (2016-2021) & (US$ Million)
Table 108. Janssen Global Services Recent Development
Table 109. Bioverativ Company Details
Table 110. Bioverativ Business Overview
Table 111. Bioverativ Bleeding Disorders Product
Table 112. Bioverativ Revenue in Bleeding Disorders Business (2016-2021) & (US$ Million)
Table 113. Bioverativ Recent Development
Table 114. Amgen Company Details
Table 115. Amgen Business Overview
Table 116. Amgen Bleeding Disorders Product
Table 117. Amgen Revenue in Bleeding Disorders Business (2016-2021) & (US$ Million)
Table 118. Amgen Recent Development
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Bleeding Disorders Market Share by Type: 2020 VS 2027
Figure 2. Plasma-derived Coagulation Factor Concentrates Features
Figure 3. Recombinant Coagulation Factor Concentrates Features
Figure 4. Desmopressin Features
Figure 5. Antifibrinolytics Features
Figure 6. Fibrin Sealants Features
Figure 7. Others Features
Figure 8. Global Bleeding Disorders Market Share by Application: 2020 VS 2027
Figure 9. Hemophilia A Case Studies
Figure 10. Hemophilia B Case Studies
Figure 11. Von Willebrand Disease Case Studies
Figure 12. Others Case Studies
Figure 13. Bleeding Disorders Report Years Considered
Figure 14. Global Bleeding Disorders Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 15. Global Bleeding Disorders Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global Bleeding Disorders Market Share by Regions: 2020 VS 2027
Figure 17. Global Bleeding Disorders Market Share by Regions (2022-2027)
Figure 18. Global Bleeding Disorders Market Share by Players in 2020
Figure 19. Global Top Bleeding Disorders Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bleeding Disorders as of 2020
Figure 20. The Top 10 and 5 Players Market Share by Bleeding Disorders Revenue in 2020
Figure 21. Global Bleeding Disorders Revenue Market Share by Type (2016-2021)
Figure 22. Global Bleeding Disorders Revenue Market Share by Type (2022-2027)
Figure 23. North America Bleeding Disorders Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. North America Bleeding Disorders Market Share by Type (2016-2027)
Figure 25. North America Bleeding Disorders Market Share by Application (2016-2027)
Figure 26. North America Bleeding Disorders Market Share by Country (2016-2027)
Figure 27. United States Bleeding Disorders Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Canada Bleeding Disorders Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Bleeding Disorders Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Bleeding Disorders Market Share by Type (2016-2027)
Figure 31. Europe Bleeding Disorders Market Share by Application (2016-2027)
Figure 32. Europe Bleeding Disorders Market Share by Country (2016-2027)
Figure 33. Germany Bleeding Disorders Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. France Bleeding Disorders Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. U.K. Bleeding Disorders Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Italy Bleeding Disorders Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Russia Bleeding Disorders Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Nordic Bleeding Disorders Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Bleeding Disorders Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Bleeding Disorders Market Share by Type (2016-2027)
Figure 41. Asia-Pacific Bleeding Disorders Market Share by Application (2016-2027)
Figure 42. Asia-Pacific Bleeding Disorders Market Share by Region (2016-2027)
Figure 43. China Bleeding Disorders Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Japan Bleeding Disorders Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. South Korea Bleeding Disorders Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Southeast Asia Bleeding Disorders Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. India Bleeding Disorders Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Australia Bleeding Disorders Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Bleeding Disorders Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Bleeding Disorders Market Share by Type (2016-2027)
Figure 51. Latin America Bleeding Disorders Market Share by Application (2016-2027)
Figure 52. Latin America Bleeding Disorders Market Share by Country (2016-2027)
Figure 53. Mexico Bleeding Disorders Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Brazil Bleeding Disorders Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Bleeding Disorders Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Bleeding Disorders Market Share by Type (2016-2027)
Figure 57. Middle East & Africa Bleeding Disorders Market Share by Application (2016-2027)
Figure 58. Middle East & Africa Bleeding Disorders Market Share by Country (2016-2027)
Figure 59. Turkey Bleeding Disorders Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Saudi Arabia Bleeding Disorders Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. UAE Bleeding Disorders Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Novo Nordisk Revenue Growth Rate in Bleeding Disorders Business (2016-2021)
Figure 63. Bayer Revenue Growth Rate in Bleeding Disorders Business (2016-2021)
Figure 64. Baxter International Revenue Growth Rate in Bleeding Disorders Business (2016-2021)
Figure 65. Alnylam Pharmaceuticals Revenue Growth Rate in Bleeding Disorders Business (2016-2021)
Figure 66. Pfizer Revenue Growth Rate in Bleeding Disorders Business (2016-2021)
Figure 67. Xenetic Biosciences Revenue Growth Rate in Bleeding Disorders Business (2016-2021)
Figure 68. Bristol-Myers Squibb Company Revenue Growth Rate in Bleeding Disorders Business (2016-2021)
Figure 69. Sanofi Revenue Growth Rate in Bleeding Disorders Business (2016-2021)
Figure 70. Janssen Global Services Revenue Growth Rate in Bleeding Disorders Business (2016-2021)
Figure 71. Bioverativ Revenue Growth Rate in Bleeding Disorders Business (2016-2021)
Figure 72. Amgen Revenue Growth Rate in Bleeding Disorders Business (2016-2021)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed
世界の血友病A・B組換え因子補充療法市場規模・現状・予測（2021年-2027年） Haemophilia is a group of inherited genetic disorders which causes abnormal or exaggerated bleeding. It impairs the normal mechanism of blood clotting after an injury. Internal bleeding inside the joint or inside brain is commonly seen in the patients with severe to moderate haemophilia. Its symptom…- 世界のヒト凝固因子Ⅷ市場 2021：企業別、地域別、種類・用途別 The Human Coagulation Factor Ⅷ market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regu…
- 世界の抗血友病因子（AHF）・フォンウィルブランド因子（VWF）複合体市場規模・現状・予測（2021年-2027年） Antihemophilic and von Willebrand factor complex is a combination medicine used to treat or prevent bleeding episodes in people with von Willebrand disease. Antihemophilic and von Willebrand factor complex is also used to treat or prevent bleeding episodes in people with hemophilia A. Market Analysi…
- 世界の希少血友病因子市場 2021：企業別、地域別、種類・用途別 The Rare Hemophilia Factors market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulat…
- 世界の抗血友病因子（組換え）市場規模・現状・予測（2021年-2027年） Antihemophilic factor is a naturally occurring protein in the blood that helps blood to clot. Market Analysis and Insights: Global Antihemophilic Factor (Recombinant) Market The global Antihemophilic Factor (Recombinant) market size is projected to reach US$ XX million by 2027, from US$ XX million i…